| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO I CAP USD | RVI EMERGENTES | 50,90% | 83,64% | 49,52% | 146,16% |
| JPM CHINA A-SHARE OPPORTUNITIES D (ACC) EUR | RVI CHINA | 50,90% | 26,34% | -19,63% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 50,90% | 22,07% | -24,24% | · |
| BGF EMERGING MARKETS EQUITY INCOME A6 HKD (HEDGED) | RVI EMERGENTES | 50,89% | 57,98% | 25,48% | 76,82% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME I CAP USD | RVI EMERGENTES | 50,89% | 90,39% | 52,93% | 150,51% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 50,88% | 22,03% | -24,27% | · |
| PICTET - CLEAN ENERGY TRANSITION HR EUR | RVI ENERGÍA | 50,87% | 65,26% | 48,34% | 187,55% |
| ROBECO EMERGING MARKETS EQUITIES F EUR | RVI EMERGENTES | 50,87% | 78,26% | 60,62% | 181,26% |
| SPDR MSCI USA VALUE UCITS ETF | RVI USA VALOR | 50,87% | 75,45% | 80,08% | 214,95% |
| JPM FUNDS-EMERGING MARKETS EQUITY PLUS C (ACC) EUR | RVI EMERGENTES | 50,86% | 88,30% | 62,01% | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | RVI BIOTECNOLOGÍA | 50,85% | 28,48% | · | · |
| CAPITAL GROUP ASIAN HORIZON FUND (LUX) B USD | RVI ASIA EX-JAPÓN | 50,84% | 68,83% | 18,31% | · |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO P (CLOSE) USD CAP | RVI EMERGENTES | 50,83% | 80,70% | 47,61% | 164,33% |
| WELLINGTON EMERGING MARKETS RESEARCH EQUITY D EUR ACC | RVI EMERGENTES | 50,81% | 75,89% | 33,40% | · |
| JUPITER GLOBAL EMERGING MARKETS FOCUS FUND L GBP CAP | RVI EMERGENTES | 50,80% | 65,26% | 40,09% | 131,48% |
| FIDELITY FUNDS 2 - TRANSITION MATERIALS Y-ACC-EUR | RVI MATERIAS PRIMAS | 50,79% | · | · | · |
| AMUNDI FUNDS CHINA A SHARES A USD (C) | RVI CHINA | 50,78% | 32,19% | · | · |
| GAM SUSTAINABLE EMERGING EQUITY Z EUR CAP | RVI EMERGENTES | 50,77% | 121,28% | · | · |
| GAM SUSTAINABLE EMERGING EQUITY Z USD CAP | RVI EMERGENTES | 50,76% | 120,58% | · | · |
| FIDELITY FUNDS-TECHNOLOGY OPPORTUNITIES A-DIST-EUR | RVI TECNOLOGÍA | 50,75% | 74,42% | 43,43% | · |
